Herpesvirus Antiviral Resistance
Database


    • TOP

    Lurain NS

    Mutations:

    Mutant Gene Virus Reference
    H142Y UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    G143S UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    D301N UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    D301N UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    D301N UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    G347D UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    V355A UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    N410K UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    N410K UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    N410K UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    D413E UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    D413E UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    D413E UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    S464F UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    T503I UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    T503I UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    T503I UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    L516R UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    L516R UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    L516R UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    A626V UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    P628L UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    A631G UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    M640R UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    S655L UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    S663N UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    F669L UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    S676G UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    G678S UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    N685S UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    A688V UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    A693T UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    Q697H UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    E756D UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    E756D UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    E756D UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    E756K UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    E756K UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    E756K UL54 Human betaherpesvirus 5 Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. (Jul 2003)
    E756Q UL54 Human betaherpesvirus 5 Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. (Mar 2003)
    E756Q UL54 Human betaherpesvirus 5 Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. (Mar 2003)
    E756Q UL54 Human betaherpesvirus 5 Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. (Mar 2003)
    L776M UL54 Human betaherpesvirus 5 Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. (May 2008)
    L776M UL54 Human betaherpesvirus 5 Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. (May 2008)
    L776M UL54 Human betaherpesvirus 5 Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. (May 2008)
    V787L UL54 Human betaherpesvirus 5 Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. (Mar 2003)
    V787L UL54 Human betaherpesvirus 5 Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. (Mar 2003)
    V787L UL54 Human betaherpesvirus 5 Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. (Mar 2003)
    Q868R UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    D870H UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    V873L UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    G874R UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    in884T UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    A885S UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    A885T UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    in885S UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    in885T UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    P887S UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    L890S UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    S897L UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    N898D UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    E899K UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    V953A UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    A1012V UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    L1020I UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    T1108A UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    N1116H UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    A1122T UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    G1133S UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    S1146N UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    N1147S UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    R1149T UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    G1151del UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    P1153S UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    L1156del UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    S1162L UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    S1235T UL54 Human betaherpesvirus 5 Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. (Jun 1999)
    Q19E UL97 Human betaherpesvirus 5 Antiviral drug resistance of human cytomegalovirus. (Oct 2010)
    N68D UL97 Human betaherpesvirus 5 Antiviral drug resistance of human cytomegalovirus. (Oct 2010)
    S108N UL97 Human betaherpesvirus 5 Antiviral drug resistance of human cytomegalovirus. (Oct 2010)
    L126Q UL97 Human betaherpesvirus 5 Antiviral drug resistance of human cytomegalovirus. (Oct 2010)
    G215A UL97 Human betaherpesvirus 5 Antiviral drug resistance of human cytomegalovirus. (Oct 2010)
    I244V UL97 Human betaherpesvirus 5 Antiviral drug resistance of human cytomegalovirus. (Oct 2010)
    P247S UL97 Human betaherpesvirus 5 Antiviral drug resistance of human cytomegalovirus. (Oct 2010)
    Q449K UL97 Human betaherpesvirus 5 Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing. (Oct 2001)
    G561A UL97 Human betaherpesvirus 5 Antiviral drug resistance of human cytomegalovirus. (Oct 2010)
    C603R UL97 Human betaherpesvirus 5 Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients. (Sep 2002)
    C603S UL97 Human betaherpesvirus 5 Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients. (Sep 2002)